Business Context and Reporting Period
Company: Care Investment Trust Inc. (Note: Input metadata referenced "TIPTREE INC." but the filing text identifies the registrant as Care Investment Trust Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2009
Business Overview: Care is an externally managed Real Estate Investment Trust (REIT) focused on healthcare-related real estate and mortgage debt. The company is managed by CIT Healthcare LLC, a subsidiary of CIT Group Inc. During the period, the company shifted focus from a mortgage REIT to a traditional equity REIT, selling significant portions of its loan portfolio to increase liquidity and real estate ownership.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2009 | Nine Months Ended Sep 30, 2009 | Balance Sheet (Sep 30, 2009) |
|---|---|---|---|
| Total Revenue | $5,014 | $16,190 | - |
| Net Income (Loss) | $(430) | $1,532 | - |
| EPS (Basic & Diluted) | $(0.02) | $0.08 | - |
| Cash and Cash Equivalents | - | - | $94,701 |
| Total Assets | - | - | $322,107 |
| Total Liabilities | - | - | $89,043 |
| Stockholders' Equity | - | - | $233,064 |
| Loans Held at LOCOM | - | - | $57,566 |
| Real Estate, Net | - | - | $102,298 |
Non-GAAP Measures (Nine Months Ended Sep 30, 2009):
- Funds From Operations (FFO): $11,253 ($0.56 per share)
- Adjusted Funds From Operations (AFFO): $4,577 ($0.23 per share)
Material Changes vs. Prior Period
- Revenue Composition: Rental revenue increased significantly to $9.5 million for the nine months ended Sep 30, 2009, compared to $3.0 million in the prior year, driven by the full quarter recognition of income from properties acquired in the Bickford transaction. Conversely, income from investments in loans dropped to $6.5 million from $11.8 million due to lower LIBOR rates and a reduced loan portfolio balance.
- Profitability: The company reported a net income of $1.5 million for the nine months ended Sep 30, 2009, a reversal from a net loss of $2.4 million in the same period in 2008. This improvement was aided by a $4.9 million unrealized gain on loans held at LOCOM and a $1.2 million realized gain on the sale of loans.
- Portfolio Repositioning: Loans held at LOCOM decreased from $159.9 million at Dec 31, 2008, to $57.6 million at Sep 30, 2009. This reduction resulted from sales to the Manager ($42.2 million) and third parties ($24.8 million), as well as loan repayments.
- Liquidity: Cash and cash equivalents surged to $94.7 million from $31.8 million at the end of 2008, primarily due to the sale of loans and the repayment of the warehouse line of credit.
- Debt: The company fully repaid its $37.8 million warehouse line of credit in March 2009. Mortgage notes payable remained relatively stable at $82.1 million.
Guidance, Outlook, Risks, and Unusual Items
- Strategic Alternatives: As of November 9, 2009, the Board announced it is nearing completion of a review of strategic alternatives, including a potential sale or merger of the company, or an orderly liquidation of assets accompanied by special cash distributions.
- Manager Risk (CIT Group): The Manager, CIT Healthcare LLC, is a subsidiary of CIT Group Inc., which filed for a prepackaged plan of reorganization under the U.S. Bankruptcy Code in November 2009. While the Manager was not included in the filing, the company notes that if CIT fails to achieve its reorganization objectives, it could force subsidiaries into bankruptcy, potentially challenging past transactions and impairing the Manager's ability to fulfill obligations.
- Legal Proceedings: A class action lawsuit regarding the company's IPO registration statement remains pending. The scope was narrowed to the disclosure of warehouse financing difficulties. The company has incurred approximately $0.9 million in defense costs with no loss provision accrued.
- Unusual Items: The financial results include significant non-cash adjustments, including a $4.9 million unrealized gain on loans held at LOCOM and a $1.2 million realized gain on loan sales. Expenses included $3.0 million in legal and advisory fees related to the strategic review.
Investor Verification Checklist
- Strategic Review Outcome: Verify the final decision regarding the sale, merger, or liquidation of the company announced in November 2009.
- CIT Group Bankruptcy Impact: Monitor the status of CIT Group Inc.'s reorganization to assess potential risks to the Management Agreement and the Mortgage Purchase Agreement.
- Loan Portfolio Valuation: Review the valuation methodology for the remaining $57.6 million loan portfolio held at LOCOM, specifically the reliance on third-party appraisals.
- Liquidity Sufficiency: Confirm that the $94.7 million cash balance (plus subsequent loan sale proceeds) is sufficient to meet dividend requirements and funding commitments without new financing.
- Legal Liability: Track the resolution of the IPO class action lawsuit to determine if any settlement or judgment will impact future cash flows.